Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

Merck KGaA brings on U.S. Merck's Rossetti to head R&D

Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Teva's picked its next chairman, rebel investor Landa says--and he's not in favor

Controversial Teva chairman Phillip Frost may not be leaving until the end of this year, but the company already has its next chairman lined up. That's according to one of the company's activist investors. And he doesn't much like its pick.

Vertex's Mueller steps down from R&D position

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Philips Healthcare chief DiSanzo out in management shakeup

The chief of Philips Healthcare, Deborah DiSanzo, has left the company ahead of what is expected to be disappointing Q2 earnings. The unit will now report directly to CEO Frans van Houten, The Wall Street Journal reported.

Baxter gets C-suite lined up ahead of pharma spinoff

Baxter has tapped a couple of new execs for the biopharma unit it plans to spin off next year. And with new competition in one of the division's bigger markets, its new leaders could have their work cut out for them.

Merck vet steps in to lead Third Rock's immuno-oncology upstart

Third Rock Ventures partner Cary Pfeffer is stepping aside as the start-up CEO at Jounce Therapeutics in favor of Merck veteran Richard Murray.

Former Pfizer general counsel Schulman joins Alnylam's board

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry.

Takeda COO Weber's reset plans include acquisitions, market expansion

Takeda's board swept aside concerns over having the company run by a non-Japanese executive, setting up Frenchman Christophe Weber to carry out the plans he believes are needed to turn around the faltering drugmaker.

Former Avila CEO Bosley signs on to lead MA's Editas

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry.

Teva chairman Frost will leave by the end of the year

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...